Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.

Oxybutynin, like tolterodine and other OAB drugs with drug-drug interactions, should be used with care in patients with a history of liver disease or who are on multiple drugs metabolized through the CYP450.